StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PRTA

Prothena Corporation plc

PRTA Nasdaq Pharmaceutical Preparations EDGAR ↗
$8.33
+0.21 +2.59%

Key statistics

from XBRL data in SEC filings
Market cap
$436M
Revenue (TTM)
$57.9M
Net income (TTM)
-$151M
EPS (TTM)
$-2.81
P/E ratio
Dividend yield
Free cash flow
Cash
$329M
Total assets
$350M
Gross margin
52-week range
$6.73 – $11.80

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results May 15, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Regulation FD disclosure; Other events Feb 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Results of operations (earnings release) Feb 19, 2026 8-K Director or officer change Dec 12, 2025 8-K Shareholder vote results Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Aug 27, 2025 8-K Other events Aug 6, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release) Aug 4, 2025 8-K Director or officer change Jul 30, 2025 8-K Exit or disposal costs; Director or officer change Jun 18, 2025 8-K Other events Jun 16, 2025 8-K Other events May 23, 2025 8-K Director or officer change; Shareholder vote results May 16, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K Director or officer change Dec 30, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Director or officer change; Regulation FD disclosure Sep 27, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Entered a material agreement; Other events May 28, 2024 8-K Director or officer change; Shareholder vote results May 17, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Director or officer change Feb 21, 2024 8-K Results of operations (earnings release) Feb 15, 2024 8-K Results of operations (earnings release); Other events Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023